Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study.
Eur Urol Oncol
2024
7
3
509-518
The relationship between the force applied and perceived by the surgeon during ureteral access sheath placement: ex-vivo experimental model.
World J Urol
2024
42
1
Does experience change the role of systematic biopsy during MRI-fusion biopsy of the prostate?
World J Urol
2023
41
10
2699-2705
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.
Clin Cancer Res
2023
29
10
1996-2011
Consensus statement addressing controversies and guidelines on pediatric urolithiasis.
World J Urol
2024
42
1
Treatment decision regret in long-term survivors after radical prostatectomy: a longitudinal study.
BJU Int
2023
131
5
623-630
Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.
BMC Urol
2023
23
1
Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.
Prostate Cancer Prostatic Dis
2023
26
4
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1.
Urol Oncol
2023
41
7
307-312